Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF OCTOBER 27, 2023 SAM #8004
SOLICITATION NOTICE

66 -- Notice of Intent to Sole Source to Qiagen LLC

Notice Date
10/25/2023 8:13:29 AM
 
Notice Type
Presolicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
24-000017
 
Response Due
10/27/2023 3:30:00 AM
 
Archive Date
10/28/2023
 
Point of Contact
Shasheshe Goolsby, Phone: 3018274879
 
E-Mail Address
shasheshe.goolsby@nih.gov
(shasheshe.goolsby@nih.gov)
 
Description
Title Qiagen Reagents and Consumables for the Department of Laboratory Medicine of the NIH Clinical Center Product Service Code: 6640 NAICS Code: 325413 Place of Performance: Bethesda, MD 20892 USA POTS: 24-000017 Description This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health (NIH) intends to award a fixed price contract on a sole source basis to provide Qiagen reagents and consumables for the Department of Laboratory Medicine. The purpose of this purchase contract is to supply the reagents and consumables for the Qiagen instruments, that is used to isolate DNA and RNA from various cell populations from peripheral blood of stem cell transplant patients or patients with hematological disorder. �Scope of Work The vendor will ship the supplies every 3 months as specified. Minimum Specifications These kits will provide enough reagents and consumables to process over 2000 tests. Consumables are self-contained and sterile. Technical service available �The proposed vendor, Qiagen LLC is the sole-source manufacturer and supplier of the consumables and kits that are used in the laboratory. There are other types of kits that are on the market, however, they work differently than what have been validated for our patients. These reagents have been fully validated for use in BCR-ABL fusion assay and JAK2 mutation assay. Switching to another system would entail lengthy validations and would alter the current results of our protocols. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.� Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by October 27, 2023 6:30AM EST. *** Please send your capability statements ONLY. This IS NOT a request for proposal. ***
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/2e5a87bd7e394becb3f01a64e08c673f/view)
 
Place of Performance
Address: Bethesda, MD 20892, USA
Zip Code: 20892
Country: USA
 
Record
SN06868173-F 20231027/231025230104 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.